Karvil 6.25/Karvil 12.5/Karvil 25 Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Carvedilol is generally well tolerated, partly because of the combined alpha and beta blocking properties of the molecule allow clinical efficacy to be attained with lower dosages than might be required if it were a single-action drug. The most frequently reported adverse events in patients being treated with carvedilol are related to its vasodilatory (postural hypotension, dizziness and headaches) and β-blocking (dyspnea, bronchospasm, bradycardia, malaise and asthenia) properties. Adverse events are generally more common early in therapy, are dosage-related and appear to have a lower incidence than is seen with pure β-blockade.
The adverse events reported frequently with carvedilol in clinical trials in patients with congestive heart failure were hyperuricemia, hypoglycemia, hyponatremia, increased alkaline phosphatase, glycosuria, somnolence, impotence, abnormal renal function, and albuminuria.

View ADR Reporting Link

Karvil 6.25/Karvil 12.5/Karvil 25 Adverse Reactions

carvedilol

Manufacturer:

Torrent

Distributor:

Torrent